Sexual Dysfunction News and Research

Latest Sexual Dysfunction News and Research

Lidocaine benefits breast cancer survivors who experience pain during intercourse

Lidocaine benefits breast cancer survivors who experience pain during intercourse

Scott & White Healthcare - Round Rock now offers fully integrative medicine services to Central Texans

Scott & White Healthcare - Round Rock now offers fully integrative medicine services to Central Texans

New UTMB study finds no association between testosterone therapy and blood clots in veins

New UTMB study finds no association between testosterone therapy and blood clots in veins

Psychosocial factors linked to pain in multiple sclerosis

Psychosocial factors linked to pain in multiple sclerosis

Loyola offers holistic approach to help couples manage their sexual health

Loyola offers holistic approach to help couples manage their sexual health

Can-Fite reports further progress in continuing preclinical program of CF602 sexual dysfunction drug

Can-Fite reports further progress in continuing preclinical program of CF602 sexual dysfunction drug

The Miriam Hospital offers new surgical treatment for benign prostatic hyperplasia

The Miriam Hospital offers new surgical treatment for benign prostatic hyperplasia

Low heart rate variability may place women at risk for sexual dysfunction

Low heart rate variability may place women at risk for sexual dysfunction

Can-Fite BioPharma receives Notice of Allowance for patent covering manufacturing method of CF101 drug

Can-Fite BioPharma receives Notice of Allowance for patent covering manufacturing method of CF101 drug

Study shows increased sexual dysfunction in women following gynecologic cancer treatment

Study shows increased sexual dysfunction in women following gynecologic cancer treatment

Can-Fite BioPharma reports Q1 2015 financial results, provides updates on drug development programs

Can-Fite BioPharma reports Q1 2015 financial results, provides updates on drug development programs

Endo Pharmaceuticals supports efforts to bring first ever treatment guidelines for Peyronie's Disease

Endo Pharmaceuticals supports efforts to bring first ever treatment guidelines for Peyronie's Disease

Can-Fite receives EMA clearance to begin CF102 Phase II trial for treatment of HCC patients in Europe

Can-Fite receives EMA clearance to begin CF102 Phase II trial for treatment of HCC patients in Europe

Only few sexually assaulted servicewomen seek post-assault health care, study finds

Only few sexually assaulted servicewomen seek post-assault health care, study finds

Can-Fite announces favorable data from further analysis of CF101 Phase II/III study in patients with psoriasis

Can-Fite announces favorable data from further analysis of CF101 Phase II/III study in patients with psoriasis

Can-Fite seeks EMA Orphan Drug Designation for CF102 in HCC

Can-Fite seeks EMA Orphan Drug Designation for CF102 in HCC

Loyola takes holistic approach to help couples manage their sexual health

Loyola takes holistic approach to help couples manage their sexual health

Investigational S-equol nutritional supplement may alleviate certain menopause symptoms

Investigational S-equol nutritional supplement may alleviate certain menopause symptoms

Can-Fite BioPharma's CF101Phase II/III psoriasis trial fails to meet primary endpoint

Can-Fite BioPharma's CF101Phase II/III psoriasis trial fails to meet primary endpoint

Roseroot extract may be beneficial for treating major depressive disorder

Roseroot extract may be beneficial for treating major depressive disorder